Pneumococcal conjugate second or third-dose vaccines (PCVc) in Palau
Palau: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 95.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Palau, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Palau recorded 95.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
That represents a change of up 1.1% on the previous year and unchanged over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Palau peaked at 98.0% in 2016 and was at its lowest, 7.0%, in 2008.
That places Palau 38th out of 194 countries with data for 2025, putting it in the top quarter.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Palau, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 7.0% | — |
| 2009 | 18.0% | +157.1% |
| 2010 | 45.0% | +150.0% |
| 2011 | 61.0% | +35.6% |
| 2012 | 82.0% | +34.4% |
| 2013 | 93.0% | +13.4% |
| 2014 | 93.0% | +0.0% |
| 2015 | 95.0% | +2.2% |
| 2016 | 98.0% | +3.2% |
| 2017 | 89.0% | -9.2% |
| 2018 | 82.0% | -7.9% |
| 2019 | 74.0% | -9.8% |
| 2020 | 75.0% | +1.4% |
| 2021 | 77.0% | +2.7% |
| 2022 | 82.0% | +6.5% |
| 2023 | 93.0% | +13.4% |
| 2024 | 94.0% | +1.1% |
| 2025 | 95.0% | +1.1% |
Palau compared with similar countries
- Palau's 95.0% is above the median for high income countries, which is 91.0%, 1.0× the median. (63 countries reporting)
- Palau's 95.0% is above the median for East Asia & Pacific, which is 81.0%, 1.2× the median. (30 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Palau changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2009 | +157.1% | 7.0% | 18.0% |
| 2010 | +150.0% | 18.0% | 45.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 12.5% | 7.0% | 18.0% | 2 |
| 2010s | 81.2% | 45.0% | 98.0% | 10 |
| 2020s | 86.0% | 75.0% | 95.0% | 6 |
Countries ranked near Palau
More health data for Palau
- Heat deaths vs projected death rates, annual growth rate 0.2689 % change on previous year (2090)
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2087)
- Estimated changes in temperature-related death rates compared to projected death rates 1,529 deaths per 1,000 people (2090)
- Number of infants who die before age 1 0 deaths (2100)
- Deaths in armed conflicts by region 0 deaths (2026)
- Deaths in armed conflicts based on where they occurred 0 deaths (2026)
- Population, male, annual growth rate -0.2518 % change on previous year (2025)
- Population, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population, male, per capita 0.5382 units per person (2025)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Palau?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Palau was 95.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Palau?
- The highest recorded value was 98.0% in 2016.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Palau?
- The lowest recorded value was 7.0% in 2008.
- How does Palau rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Palau ranks 38th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Palau?
- Over the last ten years it is unchanged. The long-run trend across the full record is rising.
- Where does this Palau data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).